Literature DB >> 19133025

Score model for the evaluation of dialysis membrane hemocompatibility.

Ansgar Erlenkötter1, Pia Endres, Bernd Nederlof, Carsten Hornig, Jörg Vienken.   

Abstract

The interaction of blood with artificial surfaces is of particular interest during hemodialysis treatments with extracorporeal blood circuits. Components of the extracorporeal blood circuit are known to have only a moderate, sometimes even an unfavorable hemocompatibility, and thus may provoke adverse biochemical or clinical sequelae. This article describes a newly established hemocompatibility assessment score. This score is based on on a standardized series of in vitro tests and is applied to commercially available hemodialysis membranes. It relates to a variety of membrane polymers, such as regenerated cellulose, diethylaminoethyl-modified cellulose, polyethersulfone/polyarylate blends and polysulfone. In order to compare different polymers used in the manufacturing of dialysis membranes, a set of the following hemocompatibility parameters was assessed and assembled to an overall score: generation of complement factor 5a, thrombin-antithrombin III-complex, release of platelet factor 4, generation and release of elastase from polymorphonuclear granulocytes, and platelet count. With respect to these parameters, the results reveal major differences between the selected dialysis membranes. This new score model proves to be an efficient tool to derive objective results, and it may, thus, be used in the future to facilitate the selection of membrane polymers with an appropriate hemocompatibility pattern for dialysis therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19133025     DOI: 10.1111/j.1525-1594.2008.00657.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  5 in total

1.  Low-density lipoprotein (LDL) apheresis reduces atherogenic and oxidative markers in uremic patients with hyperlipidemia.

Authors:  Tung-Sheng Chen; Show-Yih Liou; Hsi-Chin Wu; Fuu-Jen Tsai; Chang-Hai Tsai; Chih-Yang Huang; Yen-Lin Chang
Journal:  Int Urol Nephrol       Date:  2010-03-14       Impact factor: 2.370

2.  Hemocompatibility of silicon-based substrates for biomedical implant applications.

Authors:  Lalitha Muthusubramaniam; Rachel Lowe; William H Fissell; Lingyan Li; Roger E Marchant; Tejal A Desai; Shuvo Roy
Journal:  Ann Biomed Eng       Date:  2011-02-02       Impact factor: 3.934

3.  Haemocompatibility and ion exchange capability of nanocellulose polypyrrole membranes intended for blood purification.

Authors:  Natalia Ferraz; Daniel O Carlsson; Jaan Hong; Rolf Larsson; Bengt Fellström; Leif Nyholm; Maria Strømme; Albert Mihranyan
Journal:  J R Soc Interface       Date:  2012-02-01       Impact factor: 4.118

4.  Activation of basophils is a new and sensitive marker of biocompatibility in hemodialysis.

Authors:  Zenib Aljadi; Ladan Mansouri; Anna Nopp; Josefin M Paulsson; Ola Winqvist; Aman Russom; Mårten Ståhl; Britta Hylander; Stefan H Jacobson; Joachim Lundahl
Journal:  Artif Organs       Date:  2014-04-09       Impact factor: 3.094

Review 5.  Obstacles in haemocompatibility testing.

Authors:  W van Oeveren
Journal:  Scientifica (Cairo)       Date:  2013-05-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.